Coarctation of the aorta (CoA) accounts for 5% to 7% of congenital heart disease, with an incidence of 0.3 to 0.4 per 1000 live births. Surgery was the only choice of therapy for CoA until 1982 when balloon angioplasty became an available alternative for its treatment. Re-coarctation, aneurysm and aortic dissection remain the disadvantages of both treatments. To avoid those disadvantages, in 1990 endovascular stents were introduced for native coarctation and re-coarctation and since then they have become an alternative approach to surgical repair. The best approach to treat the CoA, whether open surgery or by stent placement, is not clear.
CITATION STYLE
Pádua, L. M. S., Garcia, L. C., Rubira, C. J., & de Oliveira Carvalho, P. E. (2012). Stent placement versus surgery for coarctation of the thoracic aorta. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd008204.pub2
Mendeley helps you to discover research relevant for your work.